Assessment of Therapeutic Quality Control in a Long-Term Anticoagulant Trial in Post-Myocardial Infarction Patients — Aïda J. Azar (1994) | RDL Network
Summary Various methods have been described to evaluate efficacy of anticoagulant therapy using the international normalized ration (INR). We compared the following approaches: (1) total INR’s or the most recent measurement; (2) percent time within therapeutic range, with INR changing directly or halfway between visits; and (3) total observation time assuming INR changing linearly. The study population comprised 1700 post myocardial infarction patients. Treatment comprised 3725 patient-years. There were 61,471 INR assessments with target therapeutic level of 2.8–4.8. Acenocoumarol as well as phenprocoumon were employed. Therapeutic achievement in the first months of treatment was low: less than 60% of INR’s were in range. Treatment stabilized after 6 months. Patients on acenocoumarol were within range 70% of the time compared to 80% for phenprocoumon. Method 3 is preferred because it incorporates time and is capable of calculating incidence rates at different INR levels. Our findings call for an urgent improvement of standard of anticoagulant control in the first months following commencement of treatment.
Stephan D. Fihn, Alain Gadisseur, Edwin Pasterkamp, F.J.M. van der Meer, W. G. M. Breukink-Engbers, Lya M. Geven-Boere, Erik van Meegen, Hanneke de Vries‐Goldschmeding, Irma Antheunissen-Anneveld, Annelies R. Van't Hoff, Derk Harderman, Margriet Smink, Frits R. Rosendaal
Talitha I. Verhoef, Georgia Ragia, Anthonius de Boer, Rita Barallon, Genovefa Kolovou, Vana Kolovou, Stavros Konstantinides, Saskia le Cessie, Efstratios Maltezos, F.J.M. van der Meer, Ken Redekop, M.G.H. Remkes, Frits R. Rosendaal, Rianne MF van Schie, Anna Tavridou, Dimitrios Tziakas, Mia Wadelius, Vangelis G. Manolopoulos, Anke H. Maitland‐van der Zee
Discussion(0)
No comments yet. Be the first to comment.